Vitamix Blender Container Recall Due to Laceration Hazard
Almost 170,000 Vitamix blenders are being recalled following reports that suggest the blades may break and pose a laceration hazard for consumers.
The Vitamix blender recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on August 28, after the manufacturer received at least 18 reports of the blades breaking. No injuries have been reported to date.
If the blade breaks while blending it may cause a laceration hazard to the user during the cleaning process or may be consumed accidently, posing internal lacerations that may require medical treatment.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The recall includes Vitamix 64-ounce Low Profile containers with part number 103208 A and blade date codes March 2012 through July 2013, shown as 03-12 and 07-13. The containers were sold with Vitamix blender models 7500, Professional Series 300, Professional Series 750, and individually. The containers have a 64 ounce capacity with a black plastic handle and lid.
The affected containers were manufactured in the United States by Vita-Mix Corporation of Cleveland, Ohio were they were sold nationwide at major retail stores and online at vita-mix.com from April 2012 through August 2013 for about $530 to $750 depending on different models whereas the individual container was sold for about $ 149.
Consumers should stop using the containers immediately and contact Vitamix at (888) 350-4386 or visit them online at vitamix.com to receive instructions on how to send the container back for free repair.
Get more articles like this sent directly to your inbox.
"*" indicates required fields
More Top Stories
A federal magistrate judge has ordered Covidien to turn over a large collection of hernia mesh complaint files to plaintiffs as the parties prepare to select potential bellwether test cases for 2025.
Four federal judges have ruled that the second group of Camp Lejeune lawsuits to be prepared for bellwether trials will involve claims of prostate cancer, kidney disease, lung cancer, liver cancer and breast cancer.
A federal judge has scheduled the initial status conference for coordinated GLP-1 RA drug stomach paralysis lawsuit pretrial proceedings for March 14.